Mochida Pharmaceutical Co., Ltd. (MFY) Income Statement
Mochida Pharmaceutical Co., Ltd. Income Statement
Last quarter (Q1 2026), Mochida Pharmaceutical Co., Ltd.'s total revenue was $31.72B, an increase of 19.11% from the same quarter last year. In Q1, Mochida Pharmaceutical Co., Ltd.'s net income was $3.18B. See Mochida Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 116.95B | $ 105.16B | $ 102.89B | $ 103.26B | $ 110.18B | |
| $ 56.26B | $ 53.79B | $ 52.07B | $ 55.12B | $ 59.55B | |
| $ 46.11B | $ 45.66B | $ 46.27B | $ 46.61B | $ 45.16B | |
| Depreciation and Amortization | $ 2.98B | $ 2.94B | $ 2.81B | $ 2.67B | $ 2.69B |
| $ 13.13B | $ 11.07B | $ 8.61B | $ 11.18B | $ 17.08B | |
| $ 10.15B | $ 8.13B | $ 5.80B | $ 8.51B | $ 14.39B | |
| $ 1.02B | $ -75.00M | $ 357.00M | $ 536.00M | $ 199.00M | |
| $ 11.17B | $ 8.05B | $ 6.16B | $ 9.04B | $ 14.59B | |
| $ 7.90B | $ 5.68B | $ 4.55B | $ 6.65B | $ 10.57B | |
| Per Share Metrics | |||||
| Basic EPS | $ 222.93 | $ 160.36 | $ 126.79 | $ 178.93 | $ 277.39 |
| Diluted EPS | $ 222.93 | $ 160.36 | $ 126.79 | $ 178.93 | $ 277.39 |
| Weighted Average Shares Outstanding | 35.45M | 35.45M | 35.86M | 37.16M | 38.10M |
| Weighted Average Shares Outstanding (Diluted) | 35.45M | 35.45M | 35.86M | 37.16M | 38.10M |
Currency in JPY
